Compare PBA & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBA | KMB |
|---|---|---|
| Founded | 1997 | 1910 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Containers/Packaging |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.3B | 31.5B |
| IPO Year | 2012 | 1994 |
| Metric | PBA | KMB |
|---|---|---|
| Price | $47.98 | $109.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 13 |
| Target Price | $60.00 | ★ $113.54 |
| AVG Volume (30 Days) | 778.0K | ★ 3.3M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | 4.58% | ★ 5.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.03 |
| Revenue | N/A | ★ $16,447,000,000.00 |
| Revenue This Year | $3.45 | $3.83 |
| Revenue Next Year | $9.15 | $3.61 |
| P/E Ratio | ★ $21.43 | $36.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.20 | $92.42 |
| 52 Week High | $51.58 | $131.53 |
| Indicator | PBA | KMB |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 53.90 |
| Support Level | $46.77 | $106.09 |
| Resistance Level | $49.82 | $110.96 |
| Average True Range (ATR) | 0.78 | 1.70 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 36.91 | 69.61 |
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports. It also has a joint venture through the Cedar LNG export terminal.
With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.